Olfactory functions scale with circuit restoration in a rapidly reversible Alzheimer's disease model

Journal of Neuroscience

Volumn 33, Issue 30, 2013, Pages 12208-12217

  Cheng, Ning ^a   Bai, Li ^a   Steuer, Elizabeth ^a   Belluscio, Leonardo ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CASPASE 3; DOXYCYCLINE; OLFACTORY MARKER PROTEIN; VESICULAR GLUTAMATE TRANSPORTER 2;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BEHAVIOR; CELL COUNT; CONTROLLED STUDY; GENOTYPE; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL NETWORK; NERVE DEGENERATION; NONHUMAN; OLFACTORY BULB; OLFACTORY DISCRIMINATION; OLFACTORY SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SMELLING;

AGNOSIA; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; AXONS; CASPASE 3; CELL COUNT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEEDING BEHAVIOR; FEMALE; FOOD; GENETIC THERAPY; HUMANS; LAC OPERON; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE DEGENERATION; ODORS; OLFACTORY BULB; RECOVERY OF FUNCTION; SMELL;

EID: 84880634842     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0291-13.2013     Document Type: Article

References (81)

1. Arnold SE, Lee EB, Moberg PJ, Stutzbach L, Kazi H, Han LY, Lee VM, Trojanowski JQ (2010) Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease. Ann Neurol 67:462-469. CrossRef Medline
2. Ashe KH, Zahs KR (2010) Probing the biology of Alzheimer's disease in mice. Neuron 66:631-645. CrossRef Medline
3. Axel R (1995) The molecular logic of smell. Sci Am 273:154-159. CrossRef Medline
4. Bacon AW, Bondi MW, Salmon DP, Murphy C (1998) Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction. Ann N Y Acad Sci 855:723-731. CrossRef Medline
5. Belluscio L, Katz LC (2001) Symmetry, stereotypy, and topography of odorant representations in mouse olfactory bulbs. J Neurosci 21:2113-2122. Medline
6. Bozza T, McGann JP, Mombaerts P, Wachowiak M (2004) In vivo imaging of neuronal activity by targeted expression of a genetically encoded probe in the mouse. Neuron 42:9-21. CrossRef Medline
7. Butler D, Hwang J, Estick C, Nishiyama A, Kumar SS, Baveghems C, Young-Oxendine HB, Wisniewski ML, Charalambides A, Bahr BA (2011) Protective effects of positive lysosomal modulation in Alzheimer's disease transgenic mouse models. PLoS One 6:e20501. CrossRef Medline
8. Callaway EM (2002) Cell type specificity of local cortical connections. J Neurocytol 31:231-237. CrossRef Medline
9. Calof AL, Hagiwara N, Holcomb JD, Mumm JS, Shou J (1996) Neurogenesis and cell death in olfactory epithelium. J Neurobiol 30:67-81. CrossRef Medline
10. Cao L, Rickenbacher GT, Rodriguez S, Moulia TW, Albers MW (2012a) The precision of axon targeting of mouse olfactory sensory neurons requires the BACE1 protease. Sci Rep 2:231. CrossRef Medline
11. Cao L, Schrank BR, Rodriguez S, Benz EG, Moulia TW, Rickenbacher GT, Gomez AC, Levites Y, Edwards SR, Golde TE, Hyman BT, Barnea G, Albers MW (2012b) Abeta alters the connectivity of olfactory neurons in the absence of amyloid plaques in vivo. Nat Commun 3:1009. CrossRef Medline
12. Chang WP, Huang X, Downs D, Cirrito JR, Koelsch G, Holtzman DM, Ghosh AK, Tang J (2011) Beta-secretase inhibitor GRL-8234 rescues agerelated cognitive decline in APP transgenic mice. FASEB J 25:775-784. CrossRef Medline
13. Cheng K, Bai L, Belluscio L (2011a) Fas-associated factor 1 as a regulator of olfactory axon guidance. J Neurosci 31:11905-11913. CrossRef Medline
14. Cheng N, Cai H, Belluscio L (2011b) In vivo olfactory model of APP-induced neurodegeneration reveals a reversible cell-autonomous function. J Neurosci 31:13699-13704. CrossRef Medline
15. Clark CM, Davatzikos C, Borthakur A, Newberg A, Leight S, Lee VM, Trojanowski JQ (2008) Biomarkers for early detection of Alzheimer pathology. Neurosignals 16:11-18. CrossRef Medline
16. Costanzo RM (2000) Rewiring the olfactory bulb: changes in odor maps following recovery from nerve transection. Chem Senses 25:199-205. CrossRef Medline
17. Cowan CM, Roskams AJ (2002) Apoptosis in the mature and developing olfactory neuroepithelium. Microsc Res Tech 58:204-215. CrossRef Medline
18. Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, Zinn AE, Casali BT, Restivo JL, Goebel WD, James MJ, Brunden KR, Wilson DA, Landreth GE (2012) ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 335:1503-1506. CrossRef Medline
19. Cummings DM, Belluscio L (2008) Charting plasticity in the regenerating maps of the mammalian olfactory bulb. Neuroscientist 14:251-263. CrossRef Medline
20. Cummings DM, Belluscio L (2010) Continuous neural plasticity in the olfactory intrabulbar circuitry. J Neurosci 30:9172-9180. CrossRef Medline
21. De Strooper B, Vassar R, Golde T (2010) The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat Rev Neurol 6:99-107. CrossRef Medline
22. Dodart JC, Bales KR, Gannon KS, Greene SJ, DeMattos RB, Mathis C, De-Long CA, Wu S, Wu X, Holtzman DM, Paul SM (2002) Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat Neurosci 5:452-457. CrossRef Medline
23. Doty RL (2009) The olfactory system and its disorders. Semin Neurol 29: 74-81. CrossRef Medline
24. Farbman AI (1990) Olfactory neurogenesis: genetic or environmental controls? Trends Neurosci 13:362-365. CrossRef Medline
25. Finlay BL, Wilson KG, Schneider GE (1979) Anomalous ipsilateral retinotectal projections in Syrian hamsters with early lesions: topography and functional capacity. J Comp Neurol 183:721-740. CrossRef Medline
26. Fukumoto H, Takahashi H, Tarui N, Matsui J, Tomita T, Hirode M, Sagayama M, Maeda R, Kawamoto M, Hirai K, Terauchi J, Sakura Y, Kakihana M, Kato K, Iwatsubo T, Miyamoto M (2010) A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer's disease. J Neurosci 30:11157-11166. CrossRef Medline
27. Gabellec MM, Panzanelli P, Sassoè-Pognetto M, Lledo PM (2007) Synapsespecific localization of vesicular glutamate transporters in the rat olfactory bulb. Eur J Neurosci 25:1373-1383. CrossRef Medline
28. Ghosal K, Vogt DL, Liang M, Shen Y, Lamb BT, Pimplikar SW (2009) Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain. Proc Natl Acad Sci U S A 106:18367-18372. CrossRef Medline
29. Gogos JA, Osborne J, Nemes A, Mendelsohn M, Axel R (2000) Genetic ablation and restoration of the olfactory topographic map. Cell 103: 609-620. CrossRef Medline
30. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89: 5547-5551. CrossRef Medline
31. Gramsbergen A, Ijkema-Paassen J (1982) CNS plasticity after hemicerebellectomy in the young rat: quantitative relations between aberrant and normal cerebello-rubral projections. Neurosci Lett 33:129-134. CrossRef Medline
32. Griff IC, Reed RR (1995) The genetic basis for specific anosmia to isovaleric acid in the mouse. Cell 83:407-414. CrossRef Medline
33. Harding JW, Wright JW (1979) Reversible effects of olfactory nerve section on behavior and biochemistry in mice. Brain Res Bull 4:17-22. CrossRef Medline
34. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356. CrossRef Medline
35. Hartman BK, Margolis FL (1975) Immunofluorescence localization of the olfactory marker protein. Brain Res 96:176-180. CrossRef Medline
36. Hawkes C (2003) Olfaction in neurodegenerative disorder. Mov Disord 18: 364-372. CrossRef Medline
37. Heneka MT, Sastre M, Dumitrescu-Ozimek L, Hanke A, Dewachter I, Kuiperi C, O'Banion K, Klockgether T, Van Leuven F, Landreth GE (2005) Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Brain 128:1442-1453. CrossRef Medline
38. Holtzman DM, Morris JC, Goate AM (2011) Alzheimer's disease: the challenge of the second century. Sci Transl Med 3:77sr71. CrossRef Medline
39. Hurtt ME, Thomas DA, Working PK, Monticello TM, Morgan KT (1988) Degeneration and regeneration of the olfactory epithelium following inhalation exposure to methyl bromide: pathology, cell kinetics, and olfactory function. Toxicol Appl Pharmacol 94:311-328. CrossRef Medline
40. Iwema CL, Fang H, Kurtz DB, Youngentob SL, Schwob JE (2004) Odorant receptor expression patterns are restored in lesion-recovered rat olfactory epithelium. J Neurosci 24:356-369. CrossRef Medline
41. Jankowsky JL, Slunt HH, Gonzales V, Savonenko AV, Wen JC, Jenkins NA, Copeland NG, Younkin LH, Lester HA, Younkin SG, Borchelt DR (2005a) Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease. PLoS Med 2:e355. CrossRef Medline
42. Jankowsky JL, Slunt HH, Gonzales V, Savonenko AV, Wen JC, Jenkins NA, Copeland NG, Younkin LH, Lester HA, Younkin SG, Borchelt DR (2005b) Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease. PLoS Med 2:e355. CrossRef
43. Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P, Heslin D, French J, Mount HT, Nixon RA, Mercken M, Bergeron C, Fraser PE, St George-Hyslop P, Westaway D (2000) A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408:979-982. CrossRef Medline
44. Jensen MT, Mottin MD, Cracchiolo JR, Leighty RE, Arendash GW (2005) Lifelong immunization with human beta-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging. Neuroscience 130:667-684. CrossRef Medline
45. John JA, Key B (2003) Axon mis-targeting in the olfactory bulb during regeneration of olfactory neuroepithelium. Chem Senses 28:773-779. CrossRef Medline
46. Kameshima N, Nanjou T, Fukuhara T, Yanagisawa D, Tooyama I (2012) Correlation of Abeta deposition in the nasal cavity with the formation of senile plaques in the brain of a transgenic mouse model of Alzheimer's disease. Neurosci Lett 513:166-169. CrossRef Medline
47. Kotilinek LA, Bacskai B, Westerman M, Kawarabayashi T, Younkin L, Hyman BT, Younkin S, Ashe KH (2002) Reversible memory loss in a mouse transgenic model of Alzheimer's disease. J Neurosci 22:6331-6335. Medline
48. LaFerla FM, Green KN (2012) Animal models of Alzheimer disease. Cold Spring Harb Perspect Med 2:11. CrossRef Medline
49. Lavie V, Becker M, Cohen-Kupiec R, Yacoby I, Koppel R, Wedenig M, Hutter-Paier B, Solomon B (2004) EFRH-phage immunization of Alzheimer's disease animal model improves behavioral performance in Morris water maze trials. J Mol Neurosci 24:105-113. CrossRef Medline
50. Lee EB, Leng LZ, Zhang B, Kwong L, Trojanowski JQ, Abel T, Lee VM (2006) Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice. J Biol Chem 281:4292-4299. CrossRef Medline
51. Lewandoski M (2001) Conditional control of gene expression in the mouse. Nat Rev Genet 2:743-755. CrossRef Medline
52. Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, Tran T, Ubeda O, Ashe KH, Frautschy SA, Cole GM (2000) Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci 20:5709-5714. Medline
53. Majumder S, Richardson A, Strong R, Oddo S (2011) Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits. PLoS One 6:e25416. CrossRef Medline
54. Mombaerts P (2006) Axonal wiring in the mouse olfactory system. Annu Rev Cell Dev Biol 22:713-737. CrossRef Medline
55. Mombaerts P, Wang F, Dulac C, Chao SK, Nemes A, Mendelsohn M, Edmondson J, Axel R (1996) Visualizing an olfactory sensory map. Cell 87:675-686. CrossRef Medline
56. Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW (2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408:982-985. CrossRef Medline
57. Nguyen MQ, Zhou Z, Marks CA, Ryba NJ, Belluscio L (2007) Prominent roles for odorant receptor coding sequences in allelic exclusion. Cell 131: 1009-1017. CrossRef Medline
58. Palop JJ, Mucke L (2010) Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat Neurosci 13:812-818. CrossRef Medline
59. Pourtier L, Sicard G (1990) Comparison of the sensitivity of C57BL/6J and AKR/J mice to airborne molecules of isovaleric acid and amyl acetate. Behav Genet 20:499-509. CrossRef Medline
60. Rajapaksha TW, Eimer WA, Bozza TC, Vassar R (2011) The Alzheimer's beta-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb. Mol Neurodegener 6:88. CrossRef Medline
61. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, et al. (1999) Immunization with amyloid-beta attenuates Alzheimer-diseaselike pathology in the PDAPP mouse. Nature 400:173-177. CrossRef Medline
62. Schofield PW, Ebrahimi H, Jones AL, Bateman GA, Murray SR (2012) An olfactory "stress test" may detect preclinical Alzheimer's disease. BMC Neurol 12:24. CrossRef Medline
63. Schwob JE, Youngentob SL (2001) Reinnervation of the olfactory bulb and functional capacity after recovery from lesions of the olfactory epithelium. Chem Senses 26:732.
64. Schwob JE, Youngentob SL, Ring G, Iwema CL, Mezza RC (1999) Reinnervation of the rat olfactory bulb after methyl bromide-induced lesin: timing and extent of reinnervation. J Comp Neurol 412:439-457. CrossRef Medline
65. Shaw CA, Li Y, Wiszniewska J, Chasse S, Zaidi SN, Jin W, Dawson B, Wilhelmsen K, Lupski JR, Belmont JW, Doody RS, Szigeti K (2011) Olfactory copy number association with age at onset of Alzheimer disease. Neurology 76:1302-1309. CrossRef Medline
66. Stevens CF (1998) Neuronal diversity: too many cell types for comfort? Curr Biol 8:R708-R710.
67. Talamo BR, Rudel R, Kosik KS, Lee VM, Neff S, Adelman L, Kauer JS (1989) Pathological changes in olfactory neurons in patients with Alzheimer's disease. Nature 337:736-739. CrossRef Medline
68. Vassalli A, Rothman A, Feinstein P, Zapotocky M, Mombaerts P (2002) Minigenes impart odorant receptor-specific axon guidance in the olfactory bulb. Neuron 35:681-696. CrossRef Medline
69. Wesson DW, Levy E, Nixon RA, Wilson DA (2010) Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer's disease mouse model. J Neurosci 30:505-514. CrossRef Medline
70. Wesson DW, Borkowski AH, Landreth GE, Nixon RA, Levy E, Wilson DA (2011) Sensory network dysfunction, behavioral impairments, and their reversibility in an Alzheimer's beta-amyloidosis mouse model. J Neurosci 31:15962-15971. CrossRef Medline
71. Willson ML, Bower AJ, Sherrard RM (2007) Developmental neural plasticity and its cognitive benefits: olivocerebellar reinnervation compensates for spatial function in the cerebellum. Eur J Neurosci 25:1475-1483. CrossRef Medline
72. Wirths O, Multhaup G, Bayer TA (2004) A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide: the first step of a fatal cascade. J Neurochem 91:513-520. CrossRef Medline
73. World Alzheimer Report (2012) Overcoming the stigma of dementia. London, UK: Alzheimer's Disease International.
74. Wysocki CJ, Whitney G, Tucker D (1977) Specific anosmia in the laboratory mouse. Behav Genet 7:171-188. CrossRef Medline
75. Yang DS, Stavrides P, Mohan PS, Kaushik S, Kumar A, Ohno M, Schmidt SD, Wesson D, Bandyopadhyay U, Jiang Y, Pawlik M, Peterhoff CM, Yang AJ, Wilson DA, St George-Hyslop P, Westaway D, Mathews PM, Levy E, Cuervo AM, Nixon RA (2011) Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits. Brain 134:258-277. CrossRef Medline
76. Yang M, Crawley JN (2009) Simple behavioral assessment of mouse olfaction. Curr Protoc Neurosci Chapter 8:Unit 8 24. CrossRef Medline
77. Yee KK, Costanzo RM (1995) Restoration of olfactory mediated behavior after olfactory bulb deafferentation. Physiol Behav 58:959-968. CrossRef Medline
78. Youngentob SL, Schwob JE (2006) Odorant identification and quality perception following methyl bromide-induced lesions of the olfactory epithelium. Behav Neurosci 120:1346-1355. CrossRef Medline
79. Youngentob SL, Schwob JE, Sheehe PR, Youngentob LM (1997) Odorant threshold following methyl bromide-induced lesions of the olfactory epithelium. Physiol Behav 62:1241-1252. CrossRef Medline
80. Yu CR, Power J, Barnea G, O'Donnell S, Brown HE, Osborne J, Axel R, Gogos JA (2004) Spontaneous neural activity is required for the establishment and maintenance of the olfactory sensory map. Neuron 42:553-566. CrossRef Medline
81. Zelcer N, Khanlou N, Clare R, Jiang Q, Reed-Geaghan EG, Landreth GE, Vinters HV, Tontonoz P (2007) Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. Proc Natl Acad Sci USA104:10601-10606. CrossRefMedline